Examples of 'open-label extension' in a sentence
Meaning of "open-label extension"
An open-label extension refers to a continuation of a clinical trial or study where both the researchers and the participants are aware of the treatment being administered. In an open-label extension, there is typically no placebo control or blinding involved. It allows for the evaluation of longer-term effects and safety of a treatment after the initial trial period
How to use "open-label extension" in a sentence
Basic
Advanced
open-label extension
An open-label extension study will follow.
This was followed by an open-label extension phase.
In an open-label extension study, one patient developed bacterial meningitis and died.
These responses persisted through 3 years of therapy in an open-label extension study.
In the open-label extension phase there was one fatal infection in a patient receiving Benlysta.
Patients completing the trial will be offered participation in an open-label extension trial.
Open-label extension study in patients with FCS.
One patient withdrew from the trial during the open-label extension.
Open-label extension studies.
Subsequently, the company has made the decision to discontinue the open-label extension.
Open-label extension period.
Patients could receive additional PAH treatment as required in the open-label extension.
Open-label extension study.
One patient was diagnosed with multiple sclerosis while in Period C open-label extension.
An open-label extension.
See also
Continued durable responses have been seen for up to 48 months in open-label extension.
The third part of the trial, an open-label extension with edasalonexent, is ongoing.
After 12 months, all boys are anticipated to receive edasalonexent in an open-label extension.
Changes in height in the long-term open-label extension studies were within expected age-appropriate norms.
Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy, results of a two-year open-label extension trial.
Week open-label extension trial was similar to that observed in the short-term, placebo-controlled trial.
Thereafter, all patients received recombinant alpha-galactosidase A in an open-label extension study.
Long-term experience in open-label extension studies with apremilast was generally comparable to the 52-week studies.
Improved physical function continued during the open-label extension up to week 136.
After completing the 36-week core study, patients could enter the long-term open-label extension.
ACR responses were maintained in the open-label extension study for up to 136 weeks.
HUMIRA has been studied in 1,696 patients with psoriasis in placebo-controlled and open-label extension studies.
Patients may roll-over into an ongoing 1-year open-label extension study.
The trial is comprised of three parts - Phase 1, Phase 2 and open-label extension.
GalaxyDMD is a recently-launched, open-label extension study.
Study REGAIN had a 3 month, double-blind, placebo-controlled treatment period followed by a 9 month open-label extension.
Long term efficacy could not be established in a 50-week, uncontrolled, open-label extension trial.
After the first year of the study, 78 patients continued into an open-label extension to week 98.
You'll also be interested in:
Examples of using Open-label
Show more
In the open-label study there was no difference in
This was followed by an open-label extension phase
An open-label trial may still be randomized
Examples of using Extension
Show more
This second extension must be authorized by a judge
The applicant shall be informed of any extension
Do not use extension cords or multiple sockets
